| Sno. |
Test
Name |
Min
Qty |
Ref.
Value |
| 1 |
A.S.O. TITRE |
0.5 ml |
Adults : upto 200 IU/ml Children : upto 150 IU/ml |
| 2 |
A/G RATIO |
|
|
| 3 |
ABDOMEN (X -RAY) |
|
|
| 4 |
ABDOMEN SCAN |
|
|
| 5 |
ABSOLUTE EOSINOPHIL COUNT |
1 ml |
100 - 400 cells/cmm |
| 6 |
ABSOLUTE LYMPHOCYTE COUNT |
2 ml |
1550 - 4000 cells/cmm. |
| 7 |
ABSOLUTE NEUTROPHIL COUNT |
2 ml |
2500 - 7000 Cells/cmm |
| 8 |
ACE ( ANGIO TENSIN CONVERTING ENZYME) |
|
8-52 U/L |
| 9 |
ACID PHOSPHATASE (PROSTATIC #) |
1 ml |
0 - 3.0 U/l |
| 10 |
ACID PHOSPHATASE (TOTAL) |
1 ml |
0 - 6.6 U/l |
| 11 |
ACTH |
1 ml |
7.2 - 63.3 pg/ml |
| 12 |
ACTH STIMULATED 17 - OHP ( B) |
|
|
| 13 |
ACTH - PM |
|
UP TO 46.0 pg/ml. |
| 14 |
ACTH STIMULATED 17 OHP |
|
|
| 15 |
ACTH STIMULATED CORTISOL |
|
|
| 16 |
ADENOSINE DEAMINASE (ADA) (ASCITIC FLUID) |
2 ml |
Normal : < 30 U/L Suspect : 30 - 40 Strong suspect : 40 - 60 Positive : > 60
ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
|
| 17 |
ADENOSINE DEAMINASE (ADA)(CSF) |
|
Normal : < 10 U/L Positive : > 10 U/L
ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
|
| 18 |
ADENOSINE DEAMINASE (ADA)(PLEURAL FLUID) |
|
Normal : < 30 U/L Suspect : 30 - 40 Strong suspect : 40 - 60 Positive : > 60
ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
|
| 19 |
ADENOSINE DEAMINASE (ADA)(SERUM) |
2 mL |
Normal : < 30 U/L Suspect : 30 - 40 Strong suspect : 40 - 60 Positive : > 60
ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
|
| 20 |
AFB STAIN |
|
|
| 21 |
AFB BACTEC 460 - AMIKACIN |
|
|
| 22 |
AFB BACTEC 460 - CIPROFLOXACIN |
|
|
| 23 |
AFB BACTEC 460 - CYCLOSERINE |
|
|
| 24 |
AFB BACTEC 460 - ETHIONAMIDE |
|
|
| 25 |
AFB BACTEC 460 - ISONIAZID (INH) |
|
|
| 26 |
AFB BACTEC 460 - KANAMYCIN |
|
|
| 27 |
AFB BACTEC 460 - OFLOXACIN |
|
|
| 28 |
AFB BACTEC 460 - PAS |
|
|
| 29 |
AFB BACTEC 460 - PYRAZINAMIDE |
|
|
| 30 |
AFB BACTEC 460 - RIFAMPICIN |
|
|
| 31 |
AFB BACTEC 460 - SIRE |
|
|
| 32 |
AFB BACTEC 460 - SIREP |
|
|
| 33 |
AFB BACTEC 460 - STREPTOMYCIN |
|
|
| 34 |
AFB BACTEC 460 -GENTAMICIN |
|
|
| 35 |
AFB CULTURE |
|
|
| 36 |
AFB CULTURE BY BACTECH - CSF |
|
|
| 37 |
AFB STAIN (BRONCHIAL WASH) |
|
|
| 38 |
AFB STAIN - CONCENTRATED METHOD |
|
|
| 39 |
AFP ( ASCITIC FLUID) |
2 ML |
|
| 40 |
AFP (ALPHA FETO PROTEINS) |
1 ML |
Normal Adults : 0 - 7.0 ng/ml
AFP (MATERNAL SERUM) Cut off 2.5 MoM 14 weeks : upto 27.9 ng/ml 69.75 15 weeks : upto 30.9 ng/ml 77.25 16 weeks : upto 36.1 ng/ml 90.25 17 weeks : upto 40.4 ng/ml 101.0 18 weeks : upto 48.3 ng/ml 120.75 19 weeks : upto 54.8 ng/ml 137.0 20 weeks : upto 64.7 ng/ml 161.75 21 weeks : upto 76.3 ng/ml 190.75 Increased in : Cirrhosis Liver, Chronic Hepatitis, Neural Tube defects, Germ cell Tumours. |
| 41 |
ALBUMIN |
0.5 ml |
Adults : 3.5 - 5.2 gm/dl Children Upto 14 Yrs : 3.8 - 5.4 gm/dl 14 - 18 Yrs : 3.2 - 4.5 gm/dl
|
| 42 |
ALBUMIN (ASCITIC FLUID) |
|
|
| 43 |
ALCOHOL |
|
|
| 44 |
ALKALINE PHOSPHATASE |
0.5 ml |
Children Male(U/L) Female(U/L) 1 - 30 Days 75- 316 48- 406 30Days-1yr 82- 383 124- 341 1yr-3yrs 104- 345 108- 317 4yrs-6yrs 93- 309 96- 297 7YRS-9YRS 86- 315 69- 325 10YRS-12YRS 42- 362 51- 332 13YRS-15YRS 74- 390 50- 162 16YRS-17YRS 52- 171 47- 119
ADULT MALES : 40-130 U/L ADULT FEMALES : 35-105 U/L |
| 45 |
ALPHA 1 ANTI TRYPSIN |
1 ML |
90 - 200 mg/dl |
| 46 |
ALTERNARIA ALTERNATA - SPECIFIC IgE |
1 ml |
Less than 0.35 KU/L : Negative 0.36 - 0.70 KU/L : Low Positive 0.71 - 3.50 KU/L : Moderate Positive 3.51 - 17.50 KU/L : High Positive More than 17.50 KU/L : Very High Positive |
| 47 |
AMPHETAMINE |
|
|
| 48 |
AMYLASE |
1 ml |
28-100 U/L |
| 49 |
AMYLASE (URINE - 24 HOURS) |
|
UPTO 1000 IU/L |
| 50 |
AMYLASE(ASCITIC FLUID) |
|
|
| 51 |
AMYLASE(PLEURAL FLUID) |
|
|
| 52 |
ANA WESTERN BLOT |
1 ml |
|
| 53 |
ANAEROBIC CULTURE |
|
|
| 54 |
ANCA |
1 ml |
|
| 55 |
ANDROSTENEDIONE |
1 ml |
MALES : 0.7 - 3.6 ng/ml
FEMALES : 0.3 - 3.5 ng/ml |
| 56 |
ANKLE JOINT AP/LAT (LEFT) |
|
|
| 57 |
ANKLE JOINT AP/LAT (RIGHT) |
|
|
| 58 |
ANKLE JOINT AP/LAT/OBLIQUE (BOTH) |
|
|
| 59 |
ANKLE JOINT AP/OBLIQUE (LEFT) |
|
|
| 60 |
ANKLE JOINT AP/OBLIQUE (RIGHT) |
|
|
| 61 |
ANTI - RNP |
|
|
| 62 |
ANTI CCP |
|
Less than 5.0 U/ml : Negative More than OR Equal to 5.0 U/ml : Positive |
| 63 |
ANTI HB c (TOTAL) |
1 ml |
|
| 64 |
ANTI HB c IgM |
1 ml |
|
| 65 |
ANTI HBe |
1 ml |
|
| 66 |
ANTI HCV |
1 ml |
|
| 67 |
ANTI TB IGA (CSF) |
|
|
| 68 |
ANTI TB IGG(CSF) |
|
|
| 69 |
ANTI TB IGG(PLEURAL FLUID) |
|
|
| 70 |
ANTI TB IGM (CSF) |
|
|
| 71 |
ANTI TPO ANTIBODIES |
0.5 ML |
0 - 34 IU/ml |
| 72 |
ANTI CENTROMERE ANTIBODY |
1 ml |
|
| 73 |
ANTI GBM ANTIBODY |
0.5 ml |
|
| 74 |
ANTI HAV IgG |
1 ml |
LESS THAN 20 IU/L : NEGATIVE MORE THAN 20 IU/L : POSITIVE |
| 75 |
ANTI HAV IgM |
1 ml |
|
| 76 |
ANTI HBs (QUANTITATIVE) |
0.5 ml |
Less than 10 IU/l : No immunity More than 10 IU/l : Acquired immunity
SUGGESTION FOR REVACCINATION :- Anti HBs Level REVACCINATION After Immunisation TO BE DONE Less than 10 IU/l - Immediately. 10 - 100 IU/l - After 3 - 6 months. 100 - 1000 IU/l - After One year 1000 - 10000 IU/l - After 3 - 5 Years More than 10000 IU/l - After 7 Years. |
| 77 |
ANTI HDV (DELTA) IgM |
1 ml |
|
| 78 |
ANTI HEV IgM |
1 ML |
|
| 79 |
ANTI LKM 1 ANTIBODIES |
|
|
| 80 |
ANTI MITOCHONDRIAL ANTIBODY |
0.5 ml |
|
| 81 |
ANTI NUCLEAR AB ( ANA/ ANF - BY IFA ) |
0.5 ML |
|
| 82 |
ANTI SMOOTH MUSCLE ANTIBODY |
1 ml |
|
| 83 |
ANTI SPERM ANTIBODY |
0.5 ML |
Less than 14 U/ml : Negative 14 U/ml -20 U/ml : Equivocal More than 20 U/ml : Positive |
| 84 |
ANTI TB IGA |
1 ml |
Less than 200 U/ml: Negative 200 - 350 U/ml: Low Positive More than 350 U/ml: Positive |
| 85 |
ANTI TB IGA (ASCITIC FLUID) |
|
|
| 86 |
ANTI TB IGG |
1 ml |
Less than 125 U/ml : Negative 125 - 225 U/ml : Low Positive More than 225 U/ml : Positive |
| 87 |
ANTI TB IGG (ASCITIC FLUID) |
|
|
| 88 |
ANTI TB IGM |
1 ml |
Less than 0.8 units : Negative 0.8 - 1.0 units : Equivocal More than 1.0 units : Positive |
| 89 |
ANTI TB IGM (ASCITIC FLUID) |
|
|
| 90 |
ANTITHROMBIN |
0.5 ML |
80 - 120 % |
| 91 |
APO LIPOPROTEIN A1 |
0.5 ml |
High Risk : Less than 100 mg/dl Normal Risk : 110 - 180 mg/dl Favourable : Above 184 mg/dl |
| 92 |
APO LIPOPROTEIN E |
|
3 - 6 mg/dl |
| 93 |
APO LIPOPROTEIN B |
0.5 ml |
High Risk : Above 180 mg/dl Normal Risk : 63 - 180 mg/dl Favourable : Less than 63 mg/dl |
| 94 |
APPENDIX |
|
|
| 95 |
ASCA |
1 mL |
Less than 0.35 KU/L : Negative 0.36 - 0.70 KU/L : Low Positive 0.71 - 3.50 KU/L : Moderate Positive 3.51 - 17.50 KU/L : High Positive More than 17.50 KU/L : Very High Positive |
| 96 |
ASPERGILLOSIS Ab |
1 ml |
Less than 0.35 KU/L : Negative 0.36 - 0.70 KU/L : Low Positive 0.71 - 3.50 KU/L : Moderate Positive 3.51 - 17.50 KU/L : High Positive More than 17.50 KU/L : Very High Positive |
| 97 |
AUDIOMETRY |
|
|
| Sno. |
Test
Name |
Min
Qty |
Ref.
Value |
| 1 |
BARBITURATES |
|
|
| 2 |
BARIUM MEAL |
|
|
| 3 |
BARIUM SWALLOW |
|
|
| 4 |
BENCE JONES PROTEINS |
5 ml |
|
| 5 |
BENZODIAZEDINE |
|
|
| 6 |
Beta 2 MICROGLOBULIN |
0.5 ml |
MALE : 604 ng/ml - 2286 ng/ml FEMALE: 607 ng/ml - 2454 ng/ml
Increased in : Multiple Myeloma, B cell Lymphoma, Rheumatoid Arthritis , SLE, Crohns Disease.
Decreased in : Renal Tubular Acidosis |
| 7 |
BETA CROSSLAPS ( DPD) |
|
FEMALE Premenopausal : 0.163 - 0.437 Postmenopausal : 0.320 - 0.782 MALE 30 - 50Yrs : 0.158 - 0.442 50 - 70Yrs : 0.16 |